Chemed Corporation announced a quarterly cash dividend of 70 cents per share, payable on December 4, 2026, to shareholders of record as of November 16, 2026. This dividend matches the amount paid in September 2026 and marks the company's 222nd consecutive quarterly dividend over 55 years as a public company. Chemed operates two subsidiaries, VITAS Healthcare and Roto-Rooter, serving hospice care and plumbing services respectively. The dividend announcement reflects Chemed's ongoing financial stability and commitment to returning value to shareholders.
Chemed Corporation's dividend announcement provides context for readers. For those following the health sector, here is Pluang's market snapshot: out of 150 priced US health stocks, 76 rose and 72 fell. Notable movers include SMMT at USD 15.26 with a 7.51% increase, NVAX at USD 10.49 up 7.26%, and OSCR at USD 30.79 down 7.20%. This data is as of Nov 06, 2026 23:12 WIB.
The Europe portable washing machine market is projected to grow from $2.52 billion in 2025 to $3.58 billion by 2034, with a CAGR of 3.98%. Growth is fueled by urban compact living, rising demand for space-saving appliances, increased consumer mobilit...
Food Lion has agreed to purchase five Winn-Dixie stores in Southern Georgia, expanding its presence to 51 stores in the state. This acquisition will bring Food Lion's total new store openings in 2026 to 15, exceeding its original target of 10. The st...
Cerebras Systems' stock fell 19.6% on June 24, 2026, after missing Q1 earnings estimates and revealing increased costs from renting third-party capacity. A subsequent report in October questioned the durability of Cerebras' chips and alleged inflated...
The global medical imaging workstations market is projected to grow from USD 6.20 billion in 2026 to USD 12.55 billion by 2036, at a CAGR of 7.3%. Growth is fueled by rising chronic disease prevalence, increased diagnostic imaging demand, and advance...
The global sacral neuromodulation market is projected to grow from $1.37 billion in 2026 to $3.92 billion by 2036, at an 11.1% CAGR. Growth is fueled by rising cases of urinary and fecal incontinence, demand for minimally invasive treatments, and an ...
